NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Transforming Migraine Relief with TMS Therapy at Countryside Neurology
Explore the groundbreaking potential of Transcranial Magnetic Stimulation (TMS) for alleviating migraines. Discover how Countryside Neurology in Palm Harbor, FL, [...]
TMS Eases Hundreds of Daily Seizures: How TMS Therapy at Countryside Neurology Can Help
Transcranial Magnetic Stimulation (TMS) therapy has emerged as a groundbreaking treatment for various neurological and psychiatric conditions, offering new hope [...]
TMS Therapy for Auditory Hallucinations in Schizophrenia: A Promising Treatment at Countryside Neurology
Schizophrenia is a complex mental health disorder characterized by a range of symptoms, including auditory hallucinations—hearing voices that are not [...]
TMS Therapy for Tinnitus Relief at Countryside Neurology: Recent Research
Tinnitus, often described as a persistent ringing in the ears, affects millions of people worldwide. This condition can significantly impact [...]
The Promise of TMS Therapy for Fibromyalgia: Insights from Recent Research
Fibromyalgia is a chronic condition characterized by widespread pain, fatigue, and cognitive difficulties. Traditional treatments often provide limited relief, leaving [...]
TMS Therapy for Parkinson’s Disease and More at Countryside Neurology
A recent article from the Michael J. Fox Foundation highlights the promising use of Transcranial Magnetic Stimulation (TMS) in treating [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social